Mechanical heart valves have improved long-term survival benefit over biological valves for patients aged 50-70 years, new ...
A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback